Gamma Pulse is proud to announce our selection for NATO's prestigious Defence Innovation Accelerator for the North Atlantic (DIANA) 2025 program. Out of more than 2,600 applicants, Gamma Pulse has been chosen as one of the 70 leading innovators to accelerate the development of dual-use technologies addressing critical defense and civilian challenges.
At the core of this recognition is our proprietary KillViD technology, which leverages advanced pulsed-power plasma to neutralize airborne biological pathogens with unmatched efficiency. Validated by INSERM, KillViD achieves 100% decontamination in a single pass, making it a game-changer for environments that demand absolute air safety, including military operations, healthcare facilities, food safety, and critical infrastructure.
The DIANA program provides access to NATO's mentors, test centers, and end-users, allowing Gamma Pulse to refine KillViD's capabilities for NATO's Chemical, Biological, Radiological, and Nuclear Defence (CBRND) needs. Through this program, we aim to enhance NATO's operational resilience by providing scalable, modular solutions that meet the rigorous demands of warfighter environments.
This milestone reinforces Gamma Pulse's commitment to delivering cutting-edge innovation that bridges military and civilian needs, positioning us at the forefront of global pathogen control and defense technology. We are honored to collaborate with NATO to redefine air safety and resilience in an era of evolving challenges.
Our selection underscores the transformative potential of KillViD technology and Gamma Pulse's relentless pursuit of excellence in innovation. We look forward to contributing to NATO's mission and accelerating the adoption of groundbreaking solutions for a safer, healthier future.
